Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novavax Inc (NASDAQ:NVAX)

Monday’s trading has closed, but NVAX is being traded in the after-hours session. After-Hours quote »
10.77
Delayed Data
As of 3:59pm ET
 -0.85 / -7.31%
Today’s Change
3.92
Today|||52-Week Range
15.01
+81.62%
Year-to-Date

Today’s Trading

Previous close11.62
Today’s open11.49
Day’s range10.74 - 11.70
Volume4,218,032
Average volume (3 months)4,630,128
Market cap$3.1B
Dividend yield--
Data as of 3:59pm ET, 08/31/2015

Growth & Valuation

Earnings growth (last year)-19.35%
Earnings growth (this year)-4.00%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+46.59%
P/E ratioNM
Price/Sales43.68
Price/Book12.09

Competitors

 Today’s
change
Today’s
% change
RDUSRadius Health Inc-3.18-4.97%
JUNOJuno Therapeutics In...-1.67-4.40%
KITEKite Pharma Inc-2.65-4.75%
HALOHalozyme Therapeutic...-0.95-5.16%
Data as of 3:59pm ET, 08/31/2015

Financials

Next reporting dateNovember 6, 2015
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$30.7M
Annual profit (last year)-$82.9M
Net profit margin-270.55%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Chief Financial Officer, Treasurer &
Senior VP
Barclay A. Phillips
Corporate headquarters
Gaithersburg, Maryland

Forecasts

Partner Offers